Literature DB >> 24732959

Treatment of acute mixed-cell leukemia with autologous hematopoietic SCT followed by allogeneic hematopoietic stem cell micro-transplantation.

Y-S Chen1, X-J Kong1, X-H Zhang1, X-L Yin1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24732959     DOI： 10.1038/bmt.2014.74

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  8 in total

1.  Allo-HSCT for acute leukemia of ambiguous lineage in adults: the comparison between standard conditioning and intensified conditioning regimens.

Authors:  Qi-Fa Liu; Zhi-Ping Fan; Mei-Qing Wu; Jing Sun; Xiu-Li Wu; Dan Xu; Qian-Li Jiang; Yu Zhang; Fen Huang; Yong-Qiang Wei; Jie Zhao; Guo-Pan Yu; Fan-Yi Meng
Journal:  Ann Hematol       Date:  2012-12-30       Impact factor: 3.673

2.  Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies.

Authors:  D L Porter; J M Connors; V M Van Deerlin; K M Duffy; C McGarigle; S L Saidman; D G Leonard; J H Antin
Journal:  J Clin Oncol       Date:  1999-04       Impact factor: 44.544

3.  Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients.

Authors:  Mei Guo; Kai-Xun Hu; Chang-Lin Yu; Qi-Yun Sun; Jian-Hui Qiao; Dan-Hong Wang; Guang-Xian Liu; Wan-Jun Sun; Li Wei; Xue-Dong Sun; Ya-Jing Huang; Jun-Xiao Qiao; Zheng Dong; Hui-Sheng Ai
Journal:  Blood       Date:  2010-10-21       Impact factor: 22.113

4.  Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression.

Authors:  Jaroslav Polák; Hana Hájková; Jacqueline Maalaufová-Soukupová; Jana Marková; Cyril Sálek; Jiří Schwarz; Cedrik Haškovec
Journal:  Exp Ther Med       Date:  2011-10-11       Impact factor: 2.447

5.  HLA-mismatched stem-cell microtransplantation as postremission therapy for acute myeloid leukemia: long-term follow-up.

Authors:  Mei Guo; Kai-Xun Hu; Guang-Xian Liu; Chang-Lin Yu; Jian-Hui Qiao; Qi-Yun Sun; Jun-Xiao Qiao; Zheng Dong; Wan-Jun Sun; Xue-Dong Sun; Hong-Li Zuo; Qiu-Hong Man; Zhi-Qing Liu; Tie-Qiang Liu; Hong-Xia Zhao; Ya-Jing Huang; Li Wei; Bing Liu; Juan Wang; Xu-Liang Shen; Hui-Sheng Ai
Journal:  J Clin Oncol       Date:  2012-10-08       Impact factor: 44.544

Review 6.  The molecular biology of mixed lineage leukemia.

Authors:  Robert K Slany
Journal:  Haematologica       Date:  2009-06-16       Impact factor: 9.941

7.  Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: a case series of a Chinese population.

Authors:  Xiao-Qian Xu; Jian-Min Wang; Shu-Qing Lü; Li Chen; Jian-Min Yang; Wei-Ping Zhang; Xian-Min Song; Jun Hou; Xiong Ni; Hui-Ying Qiu
Journal:  Haematologica       Date:  2009-05-19       Impact factor: 9.941

8.  Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification.

Authors:  Lingzhi Yan; Nana Ping; Mingqing Zhu; Aining Sun; Yongquan Xue; Changgeng Ruan; Hans G Drexler; Roderick A F Macleod; Depei Wu; Suning Chen
Journal:  Haematologica       Date:  2012-05-11       Impact factor: 9.941
  8 in total
  2 in total

1.  Effect of the microtransplantation of allogeneic hematopoietic stem cells as maintenance therapy for elderly patients with acute leukemia.

Authors:  Xiangjing Kong; Yongsheng Chen; L I Wang; Yali Zhou; Yuanyuan He; Weiye Nie; Xinhua Zhang; Xiaolin Yin
Journal:  Oncol Lett       Date:  2015-02-27       Impact factor: 2.967

Review 2.  Clinical Studies in Hematologic Microtransplantation.

Authors:  Kevin A David; Dennis Cooper; Roger Strair
Journal:  Curr Hematol Malig Rep       Date:  2017-02       Impact factor: 3.952
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.